Author Archives: John E. Fitzgibbon Jr.
IPO Traffic: Week Ending Oct. 25, 2019
IPO Traffic: Week Ending Oct. 18, 2019
Lead Manager/ # of Price Range Dollar SCOOP New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings Juniper Industrial Holdings (JIH.U) (u) UBS Investment Bank 30.00 $10.00 $10.00 $300.00 n.a. TELA Bio (TELA) Jefferies/ Piper Jaffray $69.00 n.a. Velocity Financial (VEL) Wells Fargo Securities/ Citigroup/ JMP Securities $100.00 n.a. n.a. (not […]
October 19, 2019 Read MoreIPO Traffic: Week Ending Oct. 4, 2019
IPO Traffic: Week Ending Oct. 4, 2019
The IPO Buzz: October’s Biotech Brigade
It seems every time the IPO Calendar starts to run dry, you can count on bankers filling up the pages with healthcare deals. This week is a classic example. Six IPOs are on tap for the first week of October – and five are in the healthcare sector, either biotech or biopharma companies. (We’ll have […]
September 29, 2019 Read MoreIPO Traffic: Week Ending Sept. 27, 2019
The IPO Buzz: A $1.8 Billion Week
This week’s IPO Calendar lists $1.8 billion in IPOs. By recent standards, that’s a lot of volume. But this week is an unusual one. It breaks down into just three names: Peloton Interactive (PTON proposed) plans to raise $1.1 billion. Endeavor Group Holdings (EDR proposed) expects to raise $600 million and Oportun Financial (OPRT proposed) […]
September 23, 2019 Read More